PGC-1β modulates statin-associated myotoxicity in mice
- PMID: 30511338
- DOI: 10.1007/s00204-018-2369-7
PGC-1β modulates statin-associated myotoxicity in mice
Abstract
Statins inhibit cholesterol biosynthesis and lower serum LDL-cholesterol levels. Statins are generally well tolerated, but can be associated with potentially life-threatening myopathy of unknown mechanism. We have shown previously that statins impair PGC-1β expression in human and rat skeletal muscle, suggesting that PGC-1β may play a role in statin-induced myopathy. PGC-1β is a transcriptional co-regulator controlling the expression of important genes in mitochondrial biogenesis, antioxidative capacity and energy metabolism. The principle aim of the current study was to investigate the interaction between atorvastatin and PGC-1β in more detail. We therefore treated wild-type mice and mice with selective skeletal muscle knockout of PGC-1β (PGC-1β(i)skm-/- mice) with oral atorvastatin (5 mg/kg/day) for 2 weeks. At the end of treatment, we determined body parameters, muscle function, structure, and composition as well as the function of muscle mitochondria, mitochondrial biogenesis and activation of apoptotic pathways. In wild-type mice, atorvastatin selectively impaired mitochondrial function in glycolytic muscle and caused a conversion of oxidative type IIA to glycolytic type IIB myofibers. Conversely, in oxidative muscle of wild-type mice, atorvastatin enhanced mitochondrial function via activation of mitochondrial biogenesis pathways and decreased apoptosis. In PGC-1β(i)skm-/- mice, atorvastatin induced a switch towards glycolytic fibers, caused mitochondrial dysfunction, increased mitochondrial ROS production, impaired mitochondrial proliferation and induced apoptosis in both glycolytic and oxidative skeletal muscle. Our work reveals that atorvastatin mainly affects glycolytic muscle in wild-type mice and demonstrates the importance of PGC-1β for oxidative muscle integrity during long-term exposure to a myotoxic agent.
Keywords: Apoptosis; Atorvastatin; Mitochondrial proliferation; Myopathy; PGC-1β; Reactive oxygen species (ROS).
Similar articles
-
PGC-1α plays a pivotal role in simvastatin-induced exercise impairment in mice.Acta Physiol (Oxf). 2020 Apr;228(4):e13402. doi: 10.1111/apha.13402. Epub 2019 Nov 4. Acta Physiol (Oxf). 2020. PMID: 31605661 Free PMC article.
-
The transcriptional coregulator PGC-1β controls mitochondrial function and anti-oxidant defence in skeletal muscles.Nat Commun. 2015 Dec 17;6:10210. doi: 10.1038/ncomms10210. Nat Commun. 2015. PMID: 26674215 Free PMC article.
-
Skeletal Muscle-Specific Overexpression of PGC-1α Induces Fiber-Type Conversion through Enhanced Mitochondrial Respiration and Fatty Acid Oxidation in Mice and Pigs.Int J Biol Sci. 2017 Sep 5;13(9):1152-1162. doi: 10.7150/ijbs.20132. eCollection 2017. Int J Biol Sci. 2017. PMID: 29104506 Free PMC article.
-
Coordination of mitochondrial biogenesis by PGC-1α in human skeletal muscle: A re-evaluation.Metabolism. 2018 Feb;79:42-51. doi: 10.1016/j.metabol.2017.11.001. Epub 2017 Nov 8. Metabolism. 2018. PMID: 29126696 Review.
-
New insights into mechanisms of statin-associated myotoxicity.Curr Opin Pharmacol. 2008 Jun;8(3):333-8. doi: 10.1016/j.coph.2007.12.010. Epub 2008 Feb 1. Curr Opin Pharmacol. 2008. PMID: 18243052 Review.
Cited by
-
Semi-automated quantitation of mitophagy in cells and tissues.Mech Ageing Dev. 2020 Jan;185:111196. doi: 10.1016/j.mad.2019.111196. Epub 2019 Dec 13. Mech Ageing Dev. 2020. PMID: 31843465 Free PMC article.
-
Effects of statins on mitochondrial pathways.J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):237-251. doi: 10.1002/jcsm.12654. Epub 2021 Jan 29. J Cachexia Sarcopenia Muscle. 2021. PMID: 33511728 Free PMC article. Review.
-
Effects of Simvastatin on Lipid Metabolism in Wild-Type Mice and Mice with Muscle PGC-1α Overexpression.Int J Mol Sci. 2021 May 7;22(9):4950. doi: 10.3390/ijms22094950. Int J Mol Sci. 2021. PMID: 34066911 Free PMC article.
-
Simvastatin Impairs Glucose Homeostasis in Mice Depending on PGC-1α Skeletal Muscle Expression.Biomedicines. 2020 Sep 15;8(9):351. doi: 10.3390/biomedicines8090351. Biomedicines. 2020. PMID: 32942550 Free PMC article.
-
Pan-Cancer Analysis Reveals PPRC1 as a Novel Prognostic Biomarker in Ovarian Cancer and Hepatocellular Carcinoma.Medicina (Kaunas). 2023 Apr 17;59(4):784. doi: 10.3390/medicina59040784. Medicina (Kaunas). 2023. PMID: 37109742 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- 05-PCOD-032/Agence Nationale de la Recherche/International
- ANR-10-LABX-0030-INRT/Agence Nationale de la Recherche/International
- ANR-10-IDEX-0002-02/Agence Nationale de la Recherche/International
- 2010BLAN1108-01/Agence Nationale de la Recherche/International
- 31003A_156270/Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung/International
LinkOut - more resources
Full Text Sources
Medical